مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

647
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

176
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

ASSESSMENT OF ENALAPRIL EFFECT ON INDUCING ANEMIA IN NON-AZOTEMIC DIABETIC PATIENTS

Pages

  20-24

Abstract

 Background: Angiotensin converting enzyme inhibitors (ACEIs) are known to induce ANEMIA following renal transplantation, dialysis and in renal failure patients. It seems that ACEIs cause ANEMIA via inhibition of erythropoietin synthesis or inhibiting normal proliferation of early erythroid progenitors, which are normally stimulated by angiotensin converting enzyme. There are few reports on how ACEIs induce ANEMIA in non-azotemic diabetic patients. We studied the effect of ENALAPRIL on inducing ANEMIA in non-azotemic diabetic patients. Methods: This study included 94 diabetic non-azotemic patients (serum creatinine (sCr) ≤1.5 mg/dl by jaffe reaction). Patients were divided into two groups, the first; with clinical PROTEINURIA (P+ ) having a 24 hour urine protein ≥300 mg or positive urine dipstick for protein, at least on two of three times tested, with an interval of 1 month and the second group without any signs of clinical PROTEINURIA (P- ). Only 32 patients completed the course of study; 17 as P+ and 15 as P-. Patients in both groups received 10 mg ENALAPRIL daily; and every 3 months, the dose was doubled until the dose of 40 mg/day was reached, unless any side effects emerged. Hemoglobin concentration (Hb), sCr and serum potassium (K+) were also checked regularly. Data were analyzed using t-Student test, paired t test, and chi-square test. A p value < 0.05 was considered as significant. Results: Both groups of patients were matched from the standpoint of age and sex. The average baseline sCr in P+ and P- groups were 0.8 ± 0.19 mg/dl and 0.8 ± 0.18 mg/dl respectively.( p = 0.97) After the study was completed, the average baseline sCr rose to 0.99±0.19 and 0.92±0.22 mg/dl in P+ and P- groups respectively. (p=0.32) In P+ group, mean Hb was 14.1 ±1.30 g/dl and 13.9 ± 0.99g/dl before and after the study respectively.(p = 0.28) The same parameter for the P- group was measured as 14.1±1.00 and 12.9±3.30 before and after the study respectively.( p=0.16) Conclusion: This study shows that ENALAPRIL has no significant effect on inducing ANEMIA in non-azotemic diabetic patients.  

Cites

References

  • No record.
  • Cite

    APA: Copy

    SEYRAFIAN, S., KASAEI, L., & KOSARI, R.. (2005). ASSESSMENT OF ENALAPRIL EFFECT ON INDUCING ANEMIA IN NON-AZOTEMIC DIABETIC PATIENTS. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 10(1), 20-24. SID. https://sid.ir/paper/26546/en

    Vancouver: Copy

    SEYRAFIAN S., KASAEI L., KOSARI R.. ASSESSMENT OF ENALAPRIL EFFECT ON INDUCING ANEMIA IN NON-AZOTEMIC DIABETIC PATIENTS. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2005;10(1):20-24. Available from: https://sid.ir/paper/26546/en

    IEEE: Copy

    S. SEYRAFIAN, L. KASAEI, and R. KOSARI, “ASSESSMENT OF ENALAPRIL EFFECT ON INDUCING ANEMIA IN NON-AZOTEMIC DIABETIC PATIENTS,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 10, no. 1, pp. 20–24, 2005, [Online]. Available: https://sid.ir/paper/26546/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button